Cargando…
Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder
Schizophrenia and bipolar disorder (BD) are psychiatric disorders with economic and social effects that cause disability. Treatment non-compliance is one of the major problems faced by clinicians in both schizophrenia and BD. Treatment non-compliance is associated with recurrence and impaired functi...
Autores principales: | DEVRİMCİ ÖZGÜVEN, Halise, KIR, Yağmur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Noro-Psikiyatri Arsivi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498817/ https://www.ncbi.nlm.nih.gov/pubmed/34658635 http://dx.doi.org/10.29399/npa.27480 |
Ejemplares similares
-
The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
por: Erbasan, V., et al.
Publicado: (2023) -
Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013) -
Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
por: Samalin, L, et al.
Publicado: (2010) -
A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
por: Chou, Yuan Hwa, et al.
Publicado: (2015) -
The place of long-acting injectable antipsychotics in the treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2023)